We believe that the model framework we proposed here, together with well-mixed approaches (such as in [22–25]), will be crucial to test the role of and quantify the impact of the IFN response during early acute infections, such as influenza and SARS-CoV-2, and how that may impact on disease outcome. Here, IFNA1 is linked to influenza.